Multi-target-directed drugs: new additions in 2025 and post-marketing safety surveillance of drugs marketed in 2022–2024

PHARMACOLOGICAL REPORTS · Published 2026-07-22 · DOI 10.1007/s43440-026-00879-x

Free full text

Authors (4)

Piotr Ryszkiewicz, Marta Baranowska-Kuczko, Barbara Malinowska, Eberhard Schlicker

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ryszkiewicz, P., Baranowska-Kuczko, M., Malinowska, B., et al. (2026). Multi-target-directed drugs: new additions in 2025 and post-marketing safety surveillance of drugs marketed in 2022–2024. PHARMACOLOGICAL REPORTS. https://doi.org/10.1007/s43440-026-00879-x

Related articles

• Diurnal variation of cisplatin-induced anti-tumor effect and renal toxicity in mice bearing human colon cancer cells · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Targeting mitochondrial deubiquitinase USP30 to induce mitophagy in heteroplasmic mitochondrial diseases · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Potential antidepressant properties of aminophylline in male mice exposed to chronic restraint stress · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• The effect of salidroside, an active component of Rhodiola rosea, on the metabolic activity of rat and human cytochromes P450 in preclinical studies · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Cannabidiol (CBD) modulates the serotonin–kynurenine metabolic balance in the brain of morphine-tolerant neuropathic rats · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Targeting epigenetic and DNA topology mechanisms: histone deacetylases and topoisomerase inhibitors in combination and dual inhibition approaches · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Kisspeptin-10 regulates glycosaminoglycan and decorin content in human cardiac fibroblast cultures · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022–2024) · PHARMACOLOGICAL REPORTS · 2026 · Same journal